Pediatric Early Warning Systems (PEWS) are quality improvement tools to help identify clinical deterioration in hospitalized children. Investigators from St. Jude Children's Research Hospital, together with partners across ...
Jul 10, 2023
0
14
In a review article published in The Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MGH's Department of Radiation Oncology, and co-authors describe the evolution of proton therapy ...
Jun 8, 2023
0
10
HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory HER2-positive biliary tract cancer (BTC), researchers from The University of Texas MD Anderson Cancer Center ...
Jun 3, 2023
0
6
Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely ...
Jun 2, 2023
0
26
Only a small percentage of cancer research funding gets invested into primary treatments, a study by the University of Southampton and Queen's University Belfast has revealed.
Jun 1, 2023
1
31
Despite the use of similar assessment criteria when deciding whether new cancer drugs should receive funding, there are substantial differences in drug funding decisions, across comparable high-income countries.
Jun 1, 2023
0
5
A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can't permeate the blood-brain barrier to reach the aggressive brain tumor.
May 2, 2023
0
103
St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy. The researchers found a similar survival rate between more targeted proton ...
Apr 19, 2023
0
46
Immunotherapies, such as anti-PD-1 and anti-PD-L1, have become standard first line therapies for patients with advanced renal cell carcinoma (kidney cancer). Most patients, however, eventually experience disease progression, ...
Apr 3, 2023
0
4
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
Mar 28, 2023
0
17
